O	0	8	Enhanced	Enhance	VBN	B-NP
O	9	12	DNA	DNA	NN	I-NP
O	12	13	-	-	HYPH	I-NP
O	13	20	binding	binding	NN	I-NP
O	21	29	activity	activity	NN	I-NP
O	30	32	of	of	IN	B-PP
O	33	34	a	a	DT	B-NP
O	35	40	Stat3	Stat3	NN	I-NP
O	40	41	-	-	HYPH	O
O	41	48	related	relate	VBN	B-NP
O	49	56	protein	protein	NN	I-NP
O	57	59	in	in	IN	B-PP
B-Cell	60	65	cells	cell	NNS	B-NP
O	66	77	transformed	transform	VBN	B-VP
O	78	80	by	by	IN	B-PP
O	81	84	the	the	DT	B-NP
O	85	88	Src	Src	NN	I-NP
O	89	100	oncoprotein	oncoprotein	NN	I-NP
O	100	101	.	.	.	O

O	103	112	Cytokines	Cytokine	NNS	B-NP
O	113	116	and	and	CC	O
O	117	123	growth	growth	NN	B-NP
O	124	131	factors	factor	NNS	I-NP
O	132	138	induce	induce	VBP	B-VP
O	139	147	tyrosine	tyrosine	NN	B-NP
O	148	163	phosphorylation	phosphorylation	NN	I-NP
O	164	166	of	of	IN	B-PP
O	167	173	signal	signal	NN	B-NP
O	174	185	transducers	transducer	NNS	I-NP
O	186	189	and	and	CC	I-NP
O	190	200	activators	activator	NNS	I-NP
O	201	203	of	of	IN	B-PP
O	204	217	transcription	transcription	NN	B-NP
O	218	219	(	(	(	O
O	219	224	STATs	STAT	NNS	B-NP
O	224	225	)	)	)	O
O	226	230	that	that	WDT	B-NP
O	231	239	directly	directly	RB	B-VP
O	240	248	activate	activate	VBP	I-VP
O	249	253	gene	gene	NN	B-NP
O	254	264	expression	expression	NN	I-NP
O	264	265	.	.	.	O

B-Cell	266	271	Cells	Cell	NNS	B-NP
O	272	278	stably	stably	RB	B-VP
O	279	290	transformed	transform	VBN	I-VP
O	291	293	by	by	IN	B-PP
O	294	297	the	the	DT	B-NP
O	298	301	Src	Src	NN	I-NP
O	302	310	oncogene	oncogene	NN	I-NP
O	311	319	tyrosine	tyrosine	NN	I-NP
O	320	326	kinase	kinase	NN	I-NP
O	327	331	were	be	VBD	B-VP
O	332	340	examined	examine	VBN	I-VP
O	341	344	for	for	IN	B-PP
O	345	349	STAT	STAT	NN	B-NP
O	350	357	protein	protein	NN	I-NP
O	358	368	activation	activation	NN	I-NP
O	368	369	.	.	.	O

O	370	376	Assays	Assay	NNS	B-NP
O	377	379	of	of	IN	B-PP
O	380	395	electrophoretic	electrophoretic	JJ	B-NP
O	396	404	mobility	mobility	NN	I-NP
O	404	405	,	,	,	O
O	406	409	DNA	DNA	NN	B-NP
O	409	410	-	-	HYPH	B-PP
O	410	417	binding	bind	VBG	B-NP
O	418	429	specificity	specificity	NN	I-NP
O	429	430	,	,	,	O
O	431	434	and	and	CC	O
O	435	447	antigenicity	antigenicity	NN	B-NP
O	448	457	indicated	indicate	VBD	B-VP
O	458	462	that	that	IN	B-SBAR
O	463	468	Stat3	Stat3	NN	B-NP
O	469	471	or	or	CC	O
O	472	473	a	a	DT	B-NP
O	474	481	closely	closely	RB	I-NP
O	482	489	related	related	JJ	I-NP
O	490	494	STAT	STAT	NN	I-NP
O	495	501	family	family	NN	I-NP
O	502	508	member	member	NN	I-NP
O	509	512	was	be	VBD	B-VP
O	513	527	constitutively	constitutively	RB	I-VP
O	528	537	activated	activate	VBN	I-VP
O	538	540	by	by	IN	B-PP
O	541	544	the	the	DT	B-NP
O	545	548	Src	Src	NN	I-NP
O	549	560	oncoprotein	oncoprotein	NN	I-NP
O	560	561	.	.	.	O

O	562	571	Induction	Induction	NN	B-NP
O	572	574	of	of	IN	B-PP
O	575	579	this	this	DT	B-NP
O	580	583	DNA	DNA	NN	I-NP
O	583	584	-	-	HYPH	B-NP
O	584	591	binding	binding	NN	I-NP
O	592	600	activity	activity	NN	I-NP
O	601	604	was	be	VBD	B-VP
O	605	616	accompanied	accompany	VBN	I-VP
O	617	619	by	by	IN	B-PP
O	620	628	tyrosine	tyrosine	NN	B-NP
O	629	644	phosphorylation	phosphorylation	NN	I-NP
O	645	647	of	of	IN	B-PP
O	648	653	Stat3	Stat3	NN	B-NP
O	654	657	and	and	CC	O
O	658	668	correlated	correlate	VBD	B-VP
O	669	673	with	with	IN	B-PP
O	674	677	Src	Src	NN	B-NP
O	678	692	transformation	transformation	NN	I-NP
O	692	693	.	.	.	O

O	694	699	These	These	DT	B-NP
O	700	708	findings	finding	NNS	I-NP
O	709	720	demonstrate	demonstrate	VBP	B-VP
O	721	725	that	that	IN	B-SBAR
O	726	729	Src	Src	NN	B-NP
O	730	733	can	can	MD	B-VP
O	734	742	activate	activate	VB	I-VP
O	743	747	STAT	STAT	NN	B-NP
O	748	757	signaling	signaling	NN	I-NP
O	758	766	pathways	pathway	NNS	I-NP
O	767	770	and	and	CC	O
O	771	776	raise	raise	VB	B-VP
O	777	780	the	the	DT	B-NP
O	781	792	possibility	possibility	NN	I-NP
O	793	797	that	that	IN	B-SBAR
O	798	803	Stat3	Stat3	NN	B-NP
O	804	815	contributes	contribute	VBZ	B-VP
O	816	818	to	to	TO	B-PP
O	819	830	oncogenesis	oncogenesis	NN	B-NP
O	831	833	by	by	IN	B-PP
O	834	837	Src	Src	NN	B-NP
O	837	838	.	.	.	O

